{
  "chunk_id": "V_iii_10_None_35",
  "content": "/>\nV.iii.10.4.c\n.\nEvaluating Mycosis Fungoides\nMycosis fungoides is a cutaneous manifestation of T-cell lymphoma that typically presents as some form of skin lesion and rarely progresses beyond the skin.\nFor rating purposes, it is not considered a systemic malignancy.  As such, with the revised skin rating schedule, mycosis fungoides should be evaluated under\n38 CFR 4.118, DC 7822\n.\nIf the condition progresses to a lymphoma with appropriate diagnosis, such as Non-Hodgkin’s lymphoma (active disease/active treatment phase), it would warrant an evaluation under\n38 CFR 4.118, DC 7715\n.\nNote\n:  Prior to the rating schedule change of August 13, 2018, mycosis fungoides was evaluated as\neither\na skin malignancy if manifestations were cutaneous lesions only and treatment was confined to only\nlocalized topical therapy, or\nsurgical excision (wide local excision or less extensive excision), or\nnon-Hodgkin’s lymphoma if manifestations were indicative of systemic disease with treatment consistent with systemic malignancy.",
  "title": "M21-1, Part V, Subpart iii, Chapter 10 - Skin Conditions",
  "citation": "Part V, Subpart iii, Chapter 10, Section None",
  "source_url": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180515/M21-1-Part-V-Subpart-iii-Chapter-10-Skin-Conditions",
  "updated": "",
  "scraped_at": "2025-06-16T22:45:44.520859",
  "tags": [
    "m21-1"
  ]
}